Articles

Latest news and updates about the Medicare and pharmacy industries.

June 21: Pharma Companies Sue to Oppose Listing Drug Prices in TV Ads

Posted on in Industry Updates by Amplicare Team

Plus, the latest pharmacy and healthcare news to know this week.

The Story

Last Friday, Amgen, Merck, Eli Lilly, and the Association of National Advertisers filed a lawsuit against the Trump administration, opposing a new regulation mandating that list prices of prescription drugs appear in direct-to-consumer TV ads. The new rule implemented by the Department of Health and Human Services (HHS) is set to take effect in July.

Why it Matters

The rule requires that television ads for prescription drugs covered by Medicare or Medicaid include the Wholesale Acquisition Cost if it is equal to or greater than $35 for a month’s fill or regular course of therapy. This is part of the HHS’ efforts to lower the cost of drugs and make the market more competitive. Supporters of the regulation believe that this move toward transparency will ensure that patients are not kept in the dark about the cost of their healthcare and will be able to make more informed decisions.

On the other hand, pharma companies critical of this new regulation argue that there is a discrepancy between the list price and the final price consumers pay. List prices may be much higher, as they don’t account for possible discounts and rebates pharmaceuticals provide. Simply revealing a list price also does not take into consideration differences between insurances, treatments, and patients. According to Amgen, the new rule fails to address a patient’s main concern: how much the medicine will cost them in the end.

With pharma companies pushing against the government’s efforts, it is uncertain whether this controversial regulation will actually have the chance to make a difference in costs.

More healthcare news to watch:

1. Rite Aid’s new partnership with Adobe aims to better the patient’s health and wellness experience. Forbes.

2. As prescription drug prices increase, one in 10 Americans skip doses to save money. CBS.

3. Fraud schemes involving genetic testing have been targeting Medicare beneficiaries. Tulsa World.

4. Last Monday, pharmacy organizations issued a letter to President Trump supporting DIR fee reform. Drug Topics.

5. In New York, a proposed legislation putting the state in control of negotiating prescription drug prices for Medicaid patients could lower costs and keep local pharmacies in business. AM New York.


Other Articles

Posted on by Amplicare Team

July 12: Novartis Epinephrine Shots Will Soon Be Available in U.S. Pharmacies

Amid a shortage of EpiPens, Novartis is extending the availability of its generic pre-filled epinephrine shots to pharmacies across...
Continue Reading

Posted on by Amplicare Team

Medicare Advantage: What’s Changed for 2020

Earlier this year, CMS released updates to Medicare Advantage and Part D programs for the upcoming plan year. As...
Continue Reading

Posted on by Amplicare Team

June 28: A New Bill Aims to Increase Access to Vaccinations

A bipartisan bill could help provide shingles and Tdap vaccinations to Medicare beneficiaries at no extra cost, and more...
Continue Reading

Posted on by Amplicare Team

What to Consider When Talking to Patients About Naloxone

Despite the known benefits of naloxone, approaching the conversation about its necessity with patients is not always easy for...
Continue Reading